The Drug Enforcement Administration (DEA) published a proposal to reschedule hydrocodone combination products (HCPs) from Schedule III to Schedule II. This is a proposal recommended by the Assistant Secretary for Health and supported by the DEA’s data evaluation.In your opinion, should hydrocodone combination products change to Schedule II?

Should Hydrocodone Combination Products Change to Schedule II?